The therapeutic benefits of Ketoprofen are focused on providing symptomatic relief across several key domains. Its application is within established therapeutic areas.

Easing Pain and Reducing Discomfort

Ketoprofen is used for managing symptoms related to physical discomfort, which can vary in severity, including those from headaches, muscular aches, and menstrual cramps. It is applied when symptoms create noticeable interference with daily stability, offering supportive relief when symptoms interfere with routine activities.

---

Managing Swelling, Stiffness, and Injury Symptoms

This medication contributes to therapeutic support across domains involving inflammatory or irritative states, such as swelling, stiffness, and tenderness associated with conditions like osteoarthritis and soft tissue injuries. It is commonly used across conditions characterized by periods of heightened symptoms, including rheumatoid arthritis, minor sprains and strains, and low back pain. It is relevant for easing the overall burden of symptoms and contributes to easing the overall symptom load.

Quick Fact: Relevant for Symptoms of Inflammation and Joint Discomfort

---

Providing Relief from Fever and Acute Episodes

Ketoprofen is also relevant in contexts involving heightened systemic burden, applied across domains where additional symptomatic support is needed, including the management of fever. It is often used during phases when symptoms become more noticeable, where short-term symptomatic assistance is needed.

Who can and cannot use Ketoprofen — Official Regulatory Information

The eligibility for Ketoprofen is defined by regulatory documents based on the patient's medical history and systemic health. Use is established primarily for adults for approved indications, with some over-the-counter forms permitted for adolescents aged 16 and older.

Contraindicated Populations	Restriction Type/Condition
History of NSAID/Aspirin-induced allergy (asthma, urticaria)	Absolute Prohibition
Third trimester of pregnancy	Absolute Prohibition
Treatment of pain after CABG surgery	Absolute Prohibition
Active peptic ulcer or GI bleeding	Absolute Prohibition
Severe cardiac, renal, or hepatic impairment	Absolute Prohibition

Age & Organ Restriction	Regulatory Status
Pediatric patients (under 12 to 15 years)	Safety and efficacy not established
Geriatric patients (Older Adults)	Requires caution; greater risk for serious GI events
Mild to moderate renal/hepatic impairment	Conditional use; close monitoring required
Lactating/Breastfeeding women	Not recommended

The regulatory profile mandates close monitoring for populations with a history of GI issues, hypertension, or mild heart failure. The medicine must not be used where an absolute contraindication is present, and use in children under 12 is generally not established.

Interactions with other medicines and products

Official regulatory information for Ketoprof documents clinically significant interactions based on two primary mechanisms: Pharmacodynamic Overlap and Pharmacokinetic Alteration.

---

Pharmacodynamic (PD) Overlap Risks

This medication should not generally be used with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including high-dose Aspirin, as this combination synergistically increases the risk of serious gastrointestinal bleeding and other adverse effects. An increased risk of bleeding also exists when used concurrently with Anticoagulants (such as Warfarin), Antiplatelet Agents, Corticosteroids, and Selective Serotonin Reuptake Inhibitors (SSRIs). These combinations require close monitoring.

---

Pharmacokinetic (PK) Alteration Risks

Ketoprof can alter the elimination and systemic exposure of certain co-administered drugs. Concomitant use with Lithium may elevate its plasma levels, risking toxicity. Similarly, use with Methotrexate may increase its serum levels and toxicity, particularly in patients receiving high doses. Probenecid is known to significantly increase Ketoprof’s systemic exposure, and the combination is not recommended. When taken with Diuretics or ACE Inhibitors/ARBs, the reduced effect on kidney function may diminish their antihypertensive or natriuretic actions, increasing the risk of renal function impairment, especially in older patients.

Enzyme Inhibition and Prostaglandin Synthesis

Ketoprofen acts primarily as a non-selective competitive inhibitor of Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. This molecular interaction prevents the conversion of arachidonic acid into various prostaglandin signaling molecules. This action influences the chemical pathways associated with tissue distress.

Modulation of Pain Signal Generation

By limiting the synthesis of prostaglandins, which function as key chemical sensitizers, Ketoprofen's mechanism elevates the stimulation threshold of peripheral nociceptors (pain-sensing nerve endings). This physiological alteration affects the local generation and transmission of sensory signals to the central nervous system.

Regulation of Local Tissue Dynamics

Furthermore, the drug's mechanism reduces the synthesis of mediators that typically cause vasodilation (blood vessel widening) and increased capillary permeability (leakiness). This influences local vascular responses, resulting in a reduction of fluid extravasation from the capillaries into the surrounding tissue.

Ketoprofen is administered primarily through two distinct official routes: oral for systemic action, and topical for localized application, with the required dosage and frequency dictated by the formulation.

For oral administration, the medicine is available in immediate-release (IR) and extended-release (ER) forms. The standard adult dosing regimen for chronic inflammatory conditions is typically 50 mg four times a day or 75 mg three times a day for IR capsules, while the ER capsule is administered as 200 mg once daily. The maximum daily systemic dose for most IR formulations is 300 mg. Oral forms may be taken with food, milk, or an antacid to mitigate potential gastrointestinal discomfort. Extended-release capsules must be swallowed whole and are not to be crushed or chewed, as this compromises the controlled-release properties.

Dosing is consistently guided by the principle of using the lowest effective amount for the shortest duration necessary. Dose adjustments are officially specified for specific populations: reduced maximum daily doses are advised for older adults and for patients with known hepatic or renal impairment, with maximums often ranging from 100 mg to 150 mg depending on the degree of impairment. For pediatric patients, administration rules are generally not established in official labeling.

For topical application, the gel form is applied to the skin over the affected area, typically 5 cm to 10 cm of gel, two to four times daily, with a maximum dose of 15 g per day. The gel should be gently massaged into the skin and is not to be used under occlusive dressings. If an individual misses a scheduled dose, they must skip the missed dose and resume the regular dosing schedule without doubling the subsequent dose.

Research Evidence / Overview of Studies for Ketoprof

Evidence for Managing Acute Pain and Postoperative Discomfort

Research has extensively explored the medicine in contexts involving acute or disruptive episodes, such as pain associated with surgical procedures or injury, primarily using short-term Randomized Controlled Trials (RCTs). These studies monitored changes in pain intensity over defined intervals and the time axis for recorded changes in adult populations. Findings describe patterns observed in the measured outcomes when the active substance was compared to a placebo control.

Research Base for Chronic Joint and Musculoskeletal Conditions

The evidence base for chronic conditions like osteoarthritis (OA) and rheumatoid arthritis (RA) was investigated using intermediate-term RCTs that followed participants over several weeks or months. Studies report patterns of change in measured pain scores and descriptions of how functional status was observed in the study populations. Evidence derived from settings with chronic symptom burdens often features limited follow-up durations.

Studies Examining Fever Reduction

Research exploring the medicine's role in contexts of fever was evaluated in comparative clinical studies focused on temporary physiological imbalance. The main outcomes measured were the reduction in body temperature and how long the temperature changes were observed to last. The volume of large-scale systematic reviews dedicated exclusively to fever reduction is limited.

Understanding Long-Term Evidence and Follow-up

Most high-certainty research, such as RCTs, focuses on short-term symptom changes (e.g., 6 to 12 weeks). Therefore, long-term effects are not fully established based purely on these controlled trial designs. Extended data on outcomes beyond the intermediate term are typically gathered through observational settings, and that evidence is limited in comparison to controlled trials.

Evidence in Specific Patient Populations

Research was studied for certain populations that may present with varying physiological conditions, including older adults with joint pain. Similarly, research has explored its application primarily in short-term symptom patterns for certain acute situations in the pediatric population. However, data for certain groups remain insufficient.

Areas of Research Uncertainty and Study Gaps

Key limitations noted across the research include limited follow-up durations, modest sample sizes in specific study types, and comparative evidence is lacking against certain newer therapies. Studies help show what has been observed so far, but research provides context about group patterns, not personal outcomes.

Key Studies & References

1. Ketoprofen Lysine Salt vs. Ketoprofen Acid: Assessing the Evidence for Enhanced Safety and Efficacy

Common questions about Ketoprof (FAQ)

Q: What is the main reason Ketoprof is prescribed?

A: According to official product labeling, this medicine is indicated for the treatment of symptoms associated with specific conditions. These indications include mild-to-moderate pain, menstrual pain (dysmenorrhea), rheumatoid arthritis, and osteoarthritis.

Q: Is Ketoprof considered a narcotic or opioid?

A: No. Regulatory bodies classify Ketoprofen as a nonsteroidal anti-inflammatory drug (NSAID). It is not classified as a controlled substance with abuse potential, unlike narcotics or opioids.

Q: How is Ketoprof different from ibuprofen?

A: Both Ketoprofen and ibuprofen belong to the same pharmacological group, known as nonsteroidal anti-inflammatory drugs (NSAIDs). Regulatory documents generally advise against taking this medication with other NSAIDs because of an increased risk of adverse effects.

Q: Why is Ketoprof sometimes used for menstrual pain?

A: Menstrual pain, specifically dysmenorrhea, is one of the conditions for which the immediate-release form of this medication is specifically approved in official labeling. This use is based on its established anti-inflammatory and pain-relieving properties.

Q: Is Ketoprof known to cause stomach problems?

A: Yes, official labeling contains a serious safety alert called a Black Box Warning regarding stomach risks. This warning notes the potential for serious gastrointestinal adverse events, including inflammation, bleeding, ulceration, and perforation of the stomach or intestines.

Q: What are the most common side effects listed for Ketoprof?

A: According to official product information, commonly reported side effects include gastrointestinal issues such as nausea, constipation, and diarrhea. Other side effects listed include headache, dizziness, drowsiness, and ringing in the ears (tinnitus).

Q: Can taking Ketoprof make me feel dizzy or sleepy?

A: Dizziness and drowsiness are listed among the possible central nervous system side effects in official product information. Awareness of these potential effects is noted in official documentation.

Q: Is it true that Ketoprof can affect the heart?

A: Official labeling includes a Black Box Warning about heart risks. This warning notes that the medication may increase the risk of serious and potentially fatal cardiovascular thrombotic events, such as heart attack and stroke.

Q: What happens if I take Ketoprof and drink alcohol?

A: Regulatory information advises that combining this medication with alcohol may increase the risk of serious gastrointestinal adverse effects. This includes a higher risk for ulceration and hemorrhage (bleeding).

Q: Can Ketoprof be taken with my blood pressure medicine?

A: Official documents note that this medication may diminish the blood pressure-lowering effect of certain blood pressure drugs, such as ACE-inhibitors and diuretics. Combining these medicines may also increase the risk of kidney problems.

Q: Does Ketoprof interact with common over-the-counter painkillers?

A: Concomitant use with other nonsteroidal anti-inflammatory drugs (NSAIDs) or aspirin is generally not recommended by regulatory agencies. This combination increases the potential for serious adverse effects, particularly gastrointestinal bleeding.

Q: Is there a risk of interaction between Ketoprof and aspirin?

A: Yes, co-administration with aspirin is generally not recommended by regulatory agencies. This combination increases the risk of gastrointestinal adverse effects and bleeding.

Q: What should I know about Ketoprof and kidney function?

A: Regulatory documents note that the medication can potentially cause kidney problems. Caution is advised for patients with pre-existing impaired renal function, and reduced maximum daily doses are often specified for them.

Q: Are there different forms of Ketoprof available (like gel or cream)?

A: Official documents describe the medicine as available in both oral forms, which include immediate-release and extended-release capsules. It is also available in topical forms, such as a gel.

Q: Does Ketoprof cause weight gain?

A: Official safety warnings advise patients to monitor for symptoms of congestive heart failure. These symptoms include unexplained weight gain and edema, which is swelling caused by fluid retention.

Q: Is Ketoprof a drug that people can become addicted to?

A: No. Ketoprofen is classified as a nonsteroidal anti-inflammatory drug (NSAID). It is not classified as a controlled substance by the Drug Enforcement Administration (DEA) and does not carry an addiction risk.

Q: Why do some people experience ringing in the ears with Ketoprof?

A: Ringing in the ears, also called tinnitus, is one of the reported side effects listed in the official medication information. This is one of the less common adverse events noted in clinical surveillance.

Q: Can I take Ketoprof if I am breastfeeding?

A: Official labeling states that no adequate studies in women have been performed to determine infant risk during breastfeeding. Decisions regarding use while nursing require weighing the potential benefits against the potential risks.

Q: What is the difference between Ketoprof and naproxen?

A: Like ibuprofen, naproxen also belongs to the same class of nonsteroidal anti-inflammatory drugs (NSAIDs). Regulatory documents advise against taking Ketoprofen concomitantly with naproxen due to the potential for increased adverse effects.

Q: Does long-term use of Ketoprof have known risks?

A: Yes, official labeling notes that the risk of serious cardiovascular and gastrointestinal events increases with the duration of use and dose. Due to these risks, prescribing guidance notes the importance of using the shortest duration necessary.

Q: How is Ketoprof classified by major regulatory bodies?

A: Ketoprofen is classified as a nonsteroidal anti-inflammatory drug (NSAID). This classification indicates it works primarily by reducing inflammation, fever, and pain.

Q: Are there known interactions between Ketoprof and herbal supplements?

A: Official drug interaction listings include warnings about a potential increased risk of bleeding when this medication is combined with certain herbal supplements. These may include supplements such as ginkgo, garlic, Dong Quai, and feverfew.

Q: Is Ketoprof a muscle relaxer?

A: No, Ketoprofen is classified as a nonsteroidal anti-inflammatory drug (NSAID). It is not officially classified as a skeletal muscle relaxant.

Q: What evidence exists about Ketoprof for back pain?

A: The medicine is approved in official labeling for the general treatment of mild-to-moderate pain. Back pain is a form of musculoskeletal pain that is generally covered by the broad uses of nonsteroidal anti-inflammatory drugs.

Q: Is it normal to feel nauseous when starting Ketoprof?

A: Nausea is one of the commonly reported gastrointestinal side effects listed in the official medication information. The labeling notes that oral forms may be taken with food, milk, or antacids to address potential gastrointestinal discomfort.

Q: Does Ketoprof interfere with sleep?

A: Difficulty falling asleep or staying asleep, known as insomnia, is listed among the possible central nervous system side effects in official product information.

Q: Can people with liver problems use Ketoprof?

A: Caution is advised for patients with known impaired hepatic (liver) function. Reduced maximum daily doses may be specified, and the medication can potentially increase certain liver enzymes.

Q: What is the risk of an allergic reaction to Ketoprof?

A: There is a risk of a serious allergic reaction, including anaphylaxis. The medicine is contraindicated for people who have had asthma, hives, or other allergic-type reactions to aspirin or other NSAIDs.

Q: Are there specific warnings for smokers using Ketoprof?

A: Smoking is recognized in official warnings as a risk factor that may increase the potential for serious gastrointestinal events when taking nonsteroidal anti-inflammatory drugs. Official warnings note that smoking is a risk factor.

Q: What is the purpose of the 'black box warning' often associated with NSAIDs like Ketoprof?

A: The Black Box Warnings are the most serious warnings required by the FDA. They alert users to the drug’s potential for serious cardiovascular thrombotic events (heart attack, stroke) and serious gastrointestinal adverse events (bleeding, ulceration).

Q: Does Ketoprof cause fluid retention?

A: Fluid retention (edema) is a recognized side effect of the medication. Official warnings advise caution for patients with pre-existing fluid retention, heart failure, or high blood pressure.

Q: Why is Ketoprof sometimes used for fever reduction?

A: The medication is classified as having both analgesic (pain-relieving) and antipyretic (fever-reducing) properties. Relief of fever is listed as an approved temporary use in regulatory descriptions.

Q: Is Ketoprof a controlled substance?

A: No. Ketoprofen is classified as a nonsteroidal anti-inflammatory drug (NSAID) and is not classified as a controlled substance by the DEA.

Q: Can Ketoprof be used for a headache?

A: The medication is officially approved for the treatment of general mild-to-moderate pain, which may include headaches. This falls under its general analgesic indication.

Q: How does the non-prescription version of Ketoprof differ from the prescription one?

A: The main difference is the dose. Prescription forms are available in higher strengths and extended-release capsules. Some non-prescription forms contain lower doses, which are approved for temporary relief of mild pain and aches.

Q: What are the eligibility criteria for using Ketoprof based on medical history?

A: Eligibility is assessed based on reviewing medical history for contraindications. These include a history of allergic reactions to aspirin or other NSAIDs, recent heart bypass surgery (CABG), pre-existing heart disease, stomach ulcers, or impaired kidney/liver function.

Q: Is Ketoprof used to treat rheumatoid arthritis?

A: Yes, rheumatoid arthritis is listed as one of the specific inflammatory conditions for which the prescription form of the medication is approved in official labeling.

Q: Do regulatory bodies list specific population groups that should avoid Ketoprof?

A: Yes. Contraindications are listed for patients with a history of aspirin/NSAID-induced asthma or allergies, those who have recently had heart bypass surgery (CABG), and women who are in the third trimester of pregnancy.

Q: Is Ketoprof generally considered safe for older people?

A: Official documents note that older adults are more susceptible to toxic effects, including an increased risk of serious stomach problems and kidney complications. Due to this, reduced maximum daily doses are often advised for this population.

Q: Can Ketoprof be used by teenagers?

A: Official product information states that appropriate studies have not been performed in the pediatric population. As a result, the safety and efficacy of the medication have not been established for use in individuals younger than 18 years old.

Q: What is the approved duration of use for Ketoprof?

A: Official prescribing guidance is to use the lowest effective dosage for the shortest duration necessary to relieve symptoms. This instruction is given to minimize the risk of serious cardiovascular and gastrointestinal adverse events associated with prolonged use.

Q: Why do official documents mention the need for the lowest effective amount?

A: This instruction is given because high doses, especially when used long-term, are associated with a higher risk of serious cardiovascular and gastrointestinal adverse events. Using the lowest effective amount is cited as a way to help mitigate these potential risks.

Q: What are the general guidelines about taking Ketoprof during pregnancy?

A: Official documents advise against taking the medicine at or after 20 weeks of pregnancy due to the risk of harm to the fetus and complications. The medication is specifically contraindicated during the third trimester.

How to Store and Dispose of Ketoprofen

Official labeling requires Ketoprofen oral forms to be stored at Controlled Room Temperature, defined as 20^circ to 25 C (68^circ to 77 F). The container must be kept tightly closed and protected from excess heat, moisture, and direct light. It is explicitly required to keep the medicine from freezing.

To ensure child safety, the product must be stored out of the reach of children and dispensed in a container with a child-resistant closure.

Disposal instructions prioritize drug take-back locations for unused or expired product. If take-back is unavailable, the medicine must be removed from its container, mixed with an undesirable substance (such as coffee grounds), placed in a sealed bag, and discarded in the household trash. Personal information on labels should be scratched out prior to disposal.